Triglimbrit 2mg/500mg/0.2mg Tablet
Marketer
Centaur Pharmaceuticals Pvt Ltd
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.2mg)
Overview Triglimbrit 2mg/500mg/0.2mg Tablet
Diabetic patients may find relief with GlycemiaControl 2mg/500mg/0.2mg tablets, a triple-action anti-diabetic medication. This combination therapy is indicated for adult management of type 2 diabetes mellitus, effectively regulating blood glucose. Administer GlycemiaControl with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continuous use is crucial; discontinuation without medical consultation risks elevated blood sugar, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. Remember, GlycemiaControl is a component of a comprehensive diabetes management plan, encompassing a balanced diet, regular exercise, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is the most frequent adverse reaction, characterized by sweating, dizziness, headache, and tremors. Learn to recognize these symptoms and carry a fast-acting glucose source, like sugary snacks or juice. Alcohol consumption elevates hypoglycemia risk and should be limited. Other potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, edema, blurred vision, bone fractures, and upper respiratory infections. Weight gain is possible. GlycemiaControl is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Disclose any history of heart disease to your doctor prior to commencing treatment. Consult your physician before use during pregnancy or breastfeeding. Regular blood glucose monitoring is essential, and your doctor may order blood tests to track blood cell counts and liver function.
Uses of Triglimbrit 2mg/500mg/0.2mg Tablet
Managing Type 2 diabetes
Major Benefits of Triglimbrit 2mg/500mg/0.2mg Tablet:
Administer this medication precisely as prescribed by your physician, adhering to the specified dosage and treatment schedule. Ingest the Triglimbrit 2mg/500mg/0.2mg Tablet whole; avoid chewing, crushing, or fracturing. Consume on an empty stomach.
Common Side effects of Triglimbrit 2mg/500mg/0.2mg Tablet:
- Nausea
- Diarrhea
- Abdominal pain
- Hypoglycemia (low blood glucose level)
- Loss of appetite
How to use Triglimbrit 2mg/500mg/0.2mg Tablet:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the entire tablet without chewing, crushing, or fracturing. Consume the Triglimbrit 2mg/500mg/0.2mg Tablet on an empty stomach.
How Triglimbrit 2mg/500mg/0.2mg Tablet works:
Each Triglimbrit tablet (2mg/500mg/0.2mg) combines three distinct antidiabetic agents.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol while taking Triglimbrit 2mg/500mg/0.2mg Tablets is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Triglimbrit 2mg/500mg/0.2mg Tablet during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against any risks prior to prescribing. Physician consultation is advised.
Breast feedingCONSULT YOUR DOCTOR
The use of Triglimbrit 2mg/500mg/0.2mg tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingCAUTION
Driving may be impaired by excessively low or high blood glucose levels. Refrain from driving if such symptoms arise.
KidneyUNSAFE
Patients with kidney disease should likely avoid Triglimbrit 2mg/500mg/0.2mg Tablets due to potential safety concerns. Medical advice is recommended. The use of Triglimbrit 2mg/500mg/0.2mg Tablets is contraindicated in those with severe kidney impairment.
LiverCAUTION
Caution is advised when prescribing Triglimbrit 2mg/500mg/0.2mg tablets to individuals with hepatic impairment. Dosage modifications may be necessary. Physician consultation is recommended. Initiation of Triglimbrit 2mg/500mg/0.2mg tablet therapy typically begins with a reduced dosage for patients exhibiting mild to moderate liver dysfunction; however, its use is contraindicated in cases of severe liver disease.
What if you forget to take Triglimbrit 2mg/500mg/0.2mg Tablet :
Should you forget to take your Triglimbrit 2mg/500mg/0.2mg Tablet, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Triglimbrit 2mg/500mg/0.2mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Diabetes Management |
3,018 People bought this recently